Slow-release 5-amino-salicylic acid (Pentasa) for the treatment of active Crohn's disease.
A double-blind, placebo-controlled trial of a slow-release preparation of 5-amino-salicylic acid (Pentasa) has been performed in 40 patients with active Crohn's disease. Over a 6-week period, Pentasa (1.5 g daily) was no different to the dummy tablet in terms of clinical activity (Harvey-Bradsh...
Täydet tiedot
Bibliografiset tiedot
| Päätekijät: |
Mahida, Y,
Jewell, D |
|---|
| Aineistotyyppi: | Journal article
|
|---|
| Kieli: | English |
|---|
| Julkaistu: |
1990
|
|---|